Relationships between food-related behaviors, obesity, and medication use in individuals with Smith-Magenis syndrome.
Food-seeking
Hyperphagia
Medications
Obesity
Satiety
Smith-Magenis syndrome
Journal
Research in developmental disabilities
ISSN: 1873-3379
Titre abrégé: Res Dev Disabil
Pays: United States
ID NLM: 8709782
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
05
12
2021
revised:
01
04
2022
accepted:
29
04
2022
pubmed:
22
5
2022
medline:
22
6
2022
entrez:
21
5
2022
Statut:
ppublish
Résumé
Smith-Magenis syndrome (SMS) is a complex neurodevelopmental disorder that includes obesity and food-seeking/satiety-related behaviors. This study examined associations between food-related/hyperphagic behaviors, weight, and medication use in individuals with SMS. Caregivers of individuals with SMS in the Parents and Researchers Interested in SMS (PRISMS) Patient Registry completed a demographic/medication questionnaire, the Hyperphagia Questionnaire for Clinical Trials, and the Food Related Problems Questionnaire. Among 49 participants (M Maladaptive food-related behaviors were higher in individuals with SMS with overweight/obesity, taking anti-depressants/anxiolytics, or who were male. Medications in this population should be chosen with weight-related side effects in mind.
Sections du résumé
BACKGROUND
BACKGROUND
Smith-Magenis syndrome (SMS) is a complex neurodevelopmental disorder that includes obesity and food-seeking/satiety-related behaviors.
AIMS
OBJECTIVE
This study examined associations between food-related/hyperphagic behaviors, weight, and medication use in individuals with SMS.
METHODS/PROCEDURES
METHODS
Caregivers of individuals with SMS in the Parents and Researchers Interested in SMS (PRISMS) Patient Registry completed a demographic/medication questionnaire, the Hyperphagia Questionnaire for Clinical Trials, and the Food Related Problems Questionnaire.
OUTCOMES/RESULTS
RESULTS
Among 49 participants (M
CONCLUSIONS/IMPLICATIONS
CONCLUSIONS
Maladaptive food-related behaviors were higher in individuals with SMS with overweight/obesity, taking anti-depressants/anxiolytics, or who were male. Medications in this population should be chosen with weight-related side effects in mind.
Identifiants
pubmed: 35597045
pii: S0891-4222(22)00087-7
doi: 10.1016/j.ridd.2022.104257
pii:
doi:
Substances chimiques
Anti-Anxiety Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104257Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.